Chemotherapy following radiation treatment improves progression-free survival and overall survival in adults with low-grade brain cancer
http://www.youtube.com/watch?v=pdi8vCwvfA4 CHICAGO — A chemotherapy regimen consisting of procarbazine, CCNU, and vincristine (PCV) administered following radiation therapy improved progression-free survival and overall survival in adults with low-grade gliomas, a form of brain cancer, when compared to radiation therapy alone. The findings were part of the results of a Phase III clinical trial presented today at [...]
Source: News from Mayo Clinic - Category: Databases & Libraries Source Type: news
More News: Brain | Brain Cancers | Brain Tumor | Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Databases & Libraries | Glioma | Neurology | Radiation Therapy